BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22552403)

  • 1. Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women.
    Leonard SM; Wei W; Collins SI; Pereira M; Diyaf A; Constandinou-Williams C; Young LS; Roberts S; Woodman CB
    Carcinogenesis; 2012 Jul; 33(7):1286-93. PubMed ID: 22552403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
    Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
    J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
    Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.
    Sen S; Mandal P; Bhattacharya A; Kundu S; Roy Chowdhury R; Mondal NR; Chatterjee T; Chakravarty B; Roy S; Sengupta S
    Tumour Biol; 2017 May; 39(5):1010428317699799. PubMed ID: 28459195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia.
    Ding DC; Chiang MH; Lai HC; Hsiung CA; Hsieh CY; Chu TY
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):215-20. PubMed ID: 19819061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa.
    Badaracco G; Venuti A
    Int J Oncol; 2005 Jul; 27(1):161-7. PubMed ID: 15942656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.
    Du J; Näsman A; Carlson JW; Ramqvist T; Dalianis T
    Acta Oncol; 2011 Nov; 50(8):1215-9. PubMed ID: 21726177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different DNA methylation pattern of HPV16, HPV18 and HPV51 genomes in asymptomatic HPV infection as compared to cervical neoplasia.
    Simanaviciene V; Popendikyte V; Gudleviciene Z; Zvirbliene A
    Virology; 2015 Oct; 484():227-233. PubMed ID: 26119875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia.
    Kalantari M; Calleja-Macias IE; Tewari D; Hagmar B; Lie K; Barrera-Saldana HA; Wiley DJ; Bernard HU
    J Virol; 2004 Dec; 78(23):12762-72. PubMed ID: 15542628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
    Hu T; Li YS; Chen B; Chang YF; Liu GC; Hong Y; Chen HL; Xiyang YB
    Exp Biol Med (Maywood); 2015 Oct; 240(10):1287-97. PubMed ID: 25616277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of the long control region of HPV 16 in clinical cervical specimens.
    Hong D; Ye F; Lu W; Hu Y; Wan X; Chen Y; Xie X
    Mol Med Rep; 2008; 1(4):555-60. PubMed ID: 21479449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV-CCDC106 integration alters local chromosome architecture and hijacks an enhancer by three-dimensional genome structure remodeling in cervical cancer.
    Cao C; Hong P; Huang X; Lin D; Cao G; Wang L; Feng B; Wu P; Shen H; Xu Q; Ren C; Meng Y; Zhi W; Yu R; Wei J; Ding W; Tian X; Zhang Q; Li W; Gao Q; Chen G; Li K; Sung WK; Hu Z; Wang H; Li G; Wu P
    J Genet Genomics; 2020 Aug; 47(8):437-450. PubMed ID: 33023834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype prediction based on genome-wide DNA methylation data.
    Wilhelm T
    BMC Bioinformatics; 2014 Jun; 15():193. PubMed ID: 24934728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer.
    Bhat S; Kabekkodu SP; Noronha A; Satyamoorthy K
    Biochimie; 2016 Feb; 121():298-311. PubMed ID: 26743075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV integration generates a cellular super-enhancer which functions as ecDNA to regulate genome-wide transcription.
    Tian R; Huang Z; Li L; Yuan J; Zhang Q; Meng L; Lang B; Hong Y; Zhong C; Tian X; Cui Z; Jin Z; Liu J; Huang Z; Wang Y; Chen Y; Hu Z
    Nucleic Acids Res; 2023 May; 51(9):4237-4251. PubMed ID: 36864748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
    Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
    Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.